What question did this study set out to answer?

To review the indications, contraindications, patient selection criteria, clinical outcomes, and optimal referral timing for long-term mechanical circulatory support in end-stage heart failure.

August 1, 2020Netherlands Heart JournalOpen Access

The role of long-term mechanical circulatory support in patients with advanced heart failure

View Full Paper

Ask AI

Bookmark

Why the study?

In patients with end-stage heart failure, long-term LVAD therapy is gaining importance due to rising heart failure prevalence and donor heart shortages, blurring the line between bridge to transplantation and destination therapy.

Does long-term mechanical circulatory support with an LVAD improve outcomes in patients with advanced heart failure?

Population

Patients with end-stage heart failure

Design

Review

Authors

SFS. FelixRadboud University Nijmegen NJNicolaas de JongeUtrecht University KÇKadir ÇalişkanErasmus MC

Discussion

Member takes

Implication

Supports LVAD consideration in advanced HF; leaves open need for RCTs to confirm net benefit.

Key Points

To review the indications, contraindications, patient selection criteria, clinical outcomes, and optimal referral timing for long-term mechanical circulatory support in end-stage heart failure.
Synthesized clinical evidence on left ventricular assist device (LVAD) therapy used as a bridge to transplantation and destination therapy.
Evaluated clinical management and device-related outcomes within the context of donor heart shortages in the Netherlands.
Post-LVAD implantation survival rates are 83% at 1 year, 76% at 2 years, and 70% at 3 years.
Quality of life improves substantially following implantation despite major adverse events including device-related infection, stroke, major bleeding, and right heart failure.
Early referral of candidates for mechanical circulatory support positively influences post-implantation clinical outcomes.

Structured PICO

Does long-term mechanical circulatory support with an LVAD improve outcomes in patients with advanced heart failure?

Population

Patients with end-stage/advanced heart failure

Intervention

Long-term mechanical circulatory support (MCS) with a left ventricular assist device (LVAD)

Long-term LVAD therapy offers a viable bridge or alternative to heart transplantation in advanced heart failure, improving survival and quality of life despite significant complication risks.

Cite This Study

Felix et al. (2020) studied this question.

synapsesocial.com/papers/69dcc151f3d3790cb71339d0 https://doi.org/10.1007/s12471-020-01449-3

View Full Paper

Ask AI

Bookmark

The role of long-term mechanical circulatory support in patients with advanced heart failure

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

The role of long-term mechanical circulatory support in patients with advanced heart failure

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider